135P - Can we improve patient selection for phase I clinical trials (phI1) based on immuno-oncology score prognostic index (VIO)?
| Autor: | Matos Garcia, I., Hierro, C., Martin-Liberal, J., VIAPLANA, C., Azaro, A., Brana, I., Vieito Villar, M., Saavedra, O., Gardeazabal, I., Ros, J., Prieto, P., Berché, R., Muñoz-Couselo, E., Oliveira, M., Elez Fernández, E., Felip, E., Carles, J., Tabernero, J., Dienstmann, R., Garralda, E. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v42-v42 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|